5-[3-[4-(aminomethyl)anilino]-4-(trifluoromethyl)phenyl]-3H-1,3,4-oxadiazol-2-one;hydrochloride
C16H14ClF3N4O2 — CID 156761131
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[3-[4-(aminomethyl)anilino]-4-(trifluoromethyl)phenyl]-3H-1,3,4-oxadiazol-2-one;hydrochloride
5-[3-[4-(aminomethyl)anilino]-4-(trifluoromethyl)phenyl]-3H-1,3,4-oxadiazol-2-one;hydrochloride (PubChem CID 156761131) has the molecular formula C16H14ClF3N4O2 and a molecular weight of 386.76 g/mol. Its IUPAC name is 5-[3-[4-(aminomethyl)anilino]-4-(trifluoromethyl)phenyl]-3H-1,3,4-oxadiazol-2-one;hydrochloride.
Molecular Properties
| Compound Name | 5-[3-[4-(aminomethyl)anilino]-4-(trifluoromethyl)phenyl]-3H-1,3,4-oxadiazol-2-one;hydrochloride |
|---|---|
| PubChem CID | 156761131 |
| Molecular Formula | C16H14ClF3N4O2 |
| Molecular Weight | 386.76 g/mol |
| Exact Mass | 386.08 |
| IUPAC Name | 5-[3-[4-(aminomethyl)anilino]-4-(trifluoromethyl)phenyl]-3H-1,3,4-oxadiazol-2-one;hydrochloride |
| SMILES | Cl.NCc1ccc(Nc2cc(-c3n[nH]c(=O)o3)ccc2C(F)(F)F)cc1 |
| InChI | InChI=1S/C16H13F3N4O2.ClH/c17-16(18,19)12-6-3-10(14-22-23-15(24)25-14)7-13(12)21-11-4-1-9(8-20)2-5-11;/h1-7,21H,8,20H2,(H,23,24);1H |
| InChIKey | XIXHWYDANBJPTH-UHFFFAOYSA-N |
| XLogP | 3.67 |
| TPSA | 96.94 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 386.76 |
| LogP ≤ 5 | 3.67 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156761131 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.